Welcome to “JDD September 2025 Issue Highlights,” your guided tour through this month’s must-read studies, curated by the Journal of Drugs in Dermatology Editorial Team. This issue features a Special Focus on Aesthetic Treatments alongside cutting-edge research in novel pharmacotherapies, advanced procedural techniques, and safety assessments. Whether you’re dialing in volumization with poly-L-lactic acid or strategizing long-term care for complex inflammatory conditions, you’ll find evidence-based takeaways to enhance every aspect of your practice.
Explore this month’s top picks below:
Indirect Tightening of Lower Eyelid Skin Following Poly-L-lactic Acid Treatment of the Cheeks demonstrates that the dual-depth injections of PLLA result in biostimulatory effects.
Glucagon-Like Peptide-1 Receptor Agonists Reduce Surgeries and Hospitalizations in Hidradenitis Suppurativa: A Multicenter TriNetX Cohort Study evaluates the rate of surgical abscess repairs performed and hospitalizations in a propensity score-matched cohort of patients with hidradenitis suppurativa.
Hair Transplantation in Women stresses the need for tailored approaches of treatment to enhance the results of the transplant but also support long-term maintenance of hair density.
Randomized, Double-Blind, Split-Face, Clinical Trial of Angiopoietin-1 Derived Peptide Topical Following Fractional Radiofrequency Microneedling shares results regarding enhanced skin healing and texture, reduced healing time, and increased patient satisfaction compared.
Retrospective Review of Dermal Safety Studies of Organic Sunscreens assess the dermal safety of chemical sunscreens containing the chemical filters avobenzone, octocrylene, homosalate, and octisalate.
The Atopic Dermatitis Continuum: An Updated Paradigm for a Common Disorder and a Novel Multipurpose Treatment Option highlights the triggers and continuum of four interdependent pathological presentations perpetuating disease progression.
Oral Hyaluronic Acid Supplement: Efficacy in Skin Hydration, Elasticity, and Wrinkle Depth Reduction aims to provide a comprehensive analysis of the efficacy of oral HA supplementation on various skin parameters.
Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study evaluates the efficacy of apremilast for the treatment of CCCA after 24 weeks.
Post-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management emphasizes the need for modified long-term treatment strategies.
Structured Training of Dermatology Residents in the Management of Soft-Tissue Filler-Induced Vascular Complications aims to address gaps in procedural knowledge by providing residents with a lecture series followed by a hands-on cadaveric practice session.
Find more JDD Issue Highlights here.
